Jarrow Formulas, Women’s Fem Dophilus, 60 Veggie Caps
| Supplement Facts | ||
| Serving Size: 1 Capsule | ||
| Amount Per Serving: | % DV | |
| Proprietary Probiotic Blend Lacticaseibacillus rhamnosus, GR-1 | 134 mg (5 Billion CFUxa7) | |
| Daily Value (DV) not established. Under License from Chr. Hansen A/S and protected by Chr. Hansen patents of the WO 00/35465 patented family, and others. xa7Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date. | ||
Description
- Vaginal/Urinary Tract Health
- 25+ Years of Research/Clinical Studies**
- Patented Strains
- L. Rhamnosus GR-1 & L. Reuteri RC-14
- Oral Probiotic Supplement
- Gluten Free
- Vegan
- Strains Matter
- Free of Major Allergens
- Suitable for Vegetarians/Vegans
- Jarrow Formulas’ Probiotics Contain Clinically Documented Strains
GR-1/RC-14 and Vaginal FLORA (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
Fem-Dophilus contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR-1xa1 and Limosilactobacillus reuteri RC-14xa1, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.
xa1Updates based on official taxonomy reclassification.
**25+ Years of GR-1/RC-14 research/clinical studies.
Reviews
There are no reviews yet.